Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, scientists say ...
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...
Type 2 diabetes occurs when the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood sugar levels. Medications aim to lower blood glucose, reduce A1C, and ...
When diabetes causes CKD, it’s sometimes called diabetic kidney disease. Elevated blood sugar levels that result from diabetes can damage the tiny blood vessels inside your kidneys. As a result, your ...
May 22 (Reuters) - Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's (NOVOb.CO), opens new tab Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal ...
These findings position henagliflozin at the intersection of diabetes care and longevity science. They are raising both optimism and debate over whether existing medications might also serve as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback